Morgan Stanley’s Firefly Neuroscience AIFF Stock Holding History

Morgan Stanley’s Portfolio AIFF Stock Details AIFF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$34.5K	Buy	+15,830	New	+$19.7K	﹤0.01%	6547
2025 Q4	–	Sell	-3,529	Closed	-$10.3K	–	8522
2025 Q3	$10.3K	Buy	+3,529	New	+$9.99K	﹤0.01%	6896
2025 Q2	–	Sell	-18,365	Closed	-$72.2K	–	8306
2025 Q1	$72.2K	Buy	+18,365	New	+$84.5K	﹤0.01%	6151
2023 Q3	–	Sell	-117	Closed	-$1.07K	–	7716
2023 Q2	$1.07K	Hold	117	–	–	﹤0.01%	7285
2023 Q1	$1.02K	Hold	117	–	–	﹤0.01%	7352
2022 Q4	$1.69K	Hold	117	–	–	﹤0.01%	7398
2022 Q3	$3K	Hold	117	–	–	﹤0.01%	7405
2022 Q2	$5K	Hold	117	–	–	﹤0.01%	7410
2022 Q1	$19K	Hold	117	–	–	﹤0.01%	7177
2021 Q4	$17K	Buy	+117	New	+$14K	﹤0.01%	7284

Other funds holding AIFF

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Morgan Stanley's AIFF Position: Q1 2026 in Review

Morgan Stanley opened a new position in Firefly Neuroscience (AIFF) in Q1 2026: 15,830 shares worth $34.5K. The stake represents ﹤0.01% of the portfolio and ranks #6547 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in AIFF as recently as Q3 2025.

Morgan Stanley first reported a position in AIFF in Q4 2021 and has held it in 10 quarters since. The position peaked at $72.2K in Q1 2025. 23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

Morgan Stanley held 15,830 shares of Firefly Neuroscience worth $34.5K as of Q1 2026.
Firefly Neuroscience was a new Morgan Stanley position in Q1 2026.
Firefly Neuroscience made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6547 holding.
Morgan Stanley first reported a position in Firefly Neuroscience in Q4 2021 and has held it in 10 quarters since.
Morgan Stanley's Firefly Neuroscience position peaked at $72.2K in Q1 2025.
23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.